• OPEN AN ACCOUNT
Indian Indices
Nifty
26,046.95 148.40
(0.57%)
Sensex
85,267.66 449.53
( 0.53%)
Bank Nifty
59,389.95 180.10
( 0.30%)
Nifty IT
38,274.75 177.75
( 0.47%)
Global Indices
Nasdaq
48,475.79 -249.23
(-0.51%)
Dow Jones
6,848.05 -73.95
(-1.07%)
Hang Seng
50,843.93 695.11
(1.39%)
Nikkei 225
9,668.36 -34.80
(-0.36%)
Forex
USD-INR
90.19 0.30
(0.34%)
EUR-INR
105.70 1.00
(0.96%)
GBP-INR
120.75 0.96
(0.80%)
JPY-INR
0.58 0.01
(0.91%)

EQUITY - MARKET SCREENER

Deccan Gold Mines Ltd
Industry :  Mining / Minerals / Metals
BSE Code
ISIN Demat
Book Value()
512068
INE945F01025
30.5767589
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
1858.24
EPS(TTM)
Face Value()
Div & Yield %
0
1
0
 

varanium cloud ltd
Alembic Pharma receives USFDA approval for Diltiazem hydrochloride tablets
Nov 15,2025

Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg. The approved ANDA is therapeutically equivalent to the reference listed drug (RLD), Cardizem Tablets, 30 mg, 60 mg, 90 mg, and 120 mg, of Bausch Health US, LLC.

Diltiazem hydrochloride tablets are indicated for the management of chronic stable angina and angina due to coronary artery spasm.

Alembic has a cumulative total of 230 ANDA approvals (210 final approvals and 20 tentative approvals) from USFDA.